Publications by authors named "B W Parkinson"

Introduction: Translating evidence-based practices into real-world healthcare settings is challenging, particularly in the rapidly evolving field of genomics. A pragmatic two-arm cluster-randomized clinical trial (Hide and Seek Project - HaSP) tested two implementation approaches for improving hereditary cancer referral practices with one key distinction: implementation strategies that were designed 1) explicitly using psychological theory, or 2) using healthcare professional intuition. This mixed-methods process evaluation aimed to provide insights into how and why change occurred by examining contextual determinants, identifying mechanisms of action, and exploring the role of theory.

View Article and Find Full Text PDF
Article Synopsis
  • Breast cancer poses a heightened risk of contralateral breast cancer (CBC) for BRCA1/2 variant carriers, and this study reviews strategies to mitigate that risk.
  • A systematic review including 23,840 participants from 26 studies found that secondary interventions reduced CBC incidence by 38% and improved overall survival (OS) by 45%.
  • Results indicated that treatment effectiveness varies by BRCA type and menopausal status, highlighting the importance of personalized approaches in managing risk and treatment plans.
View Article and Find Full Text PDF

Functionalizing graphene with exact pore size, specific functional groups, and precision doping poses many significant challenges. Current methods lack precision and produce random pore sizes, sites of attachment, and amounts of dopant, leading to compromised structural integrity and affecting graphene's applications. In this work, we report a strategy for the synthesis of functionalized graphitic materials with modifiable nanometer-sized pores via a Pictet-Spengler polymerization reaction.

View Article and Find Full Text PDF

Objective: Health technology assessment is used extensively by the Pharmaceutical Benefits Advisory Committee (PBAC) to inform medicine funding recommendations in Australia. The PBAC often does not recommend medicines due to uncertainties in economic modelling that result in delaying access to medicines for patients. The systematic identification of which uncertainties can be reduced with alternative evidence or the collection of additional data can help inform recommendations.

View Article and Find Full Text PDF